[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"woman-suffering-from-a-pathology-frequently-associated-with-the-presence-of-these-anti-autoantibodies-type-i-interferons\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:woman-suffering-from-a-pathology-frequently-associated-with-the-presence-of-these-anti-autoantibodies-type-i-interferons":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100544618",false,"NCT06371235","Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier","Pregiferon","Inclusion Criteria:\n\n* Pregnant woman over 18 years old\n* Woman whose gestational age is less than 30 weeks.\n* Having agreed to carry out an assay of anti-IFN alpha IgG auto-Ac before 30 weeks\n* Give birth in the inclusion center\n* Suffering from a pathology frequently associated with the presence of these anti-autoantibodies IFN alpha (lupus, severe COVID-19, myasthenia gravis, incontinentia pigmenti, hypoparathyroidism, adrenal insufficiency, diffuse candidiasis, Biermer's disease, dysthyroidism, type 1 diabetes, celiac disease, auto-thyroid disease immune system such as Graves' disease, Hashimoto's thyroiditis) or knowing its positive anti-IFN alpha autoantibody status\n* Affiliated with the Social Security system\n\nExclusion Criteria:\n\n* Patient who underwent a blood transfusion less than 2 months ago\n* Patient who received an organ transplant\n* Patient undergoing immunotherapy, stem cell therapy and\u002For other malignancy maternal, under heavy treatment (chemotherapy) less than 6 months before inclusion","FEMALE","18 Years",{"count":18,"type":19},250,"ESTIMATED","INTERVENTIONAL",[22],"NA","The main objective of the study is to evaluate the frequency of placental transfer of self-Ab directed against the mother's IFN alpha in the newborn, in all women suffering from a pathology frequently associated with the presence of these autoantibodies and in those seropositive during the pregnancy.",[25],"Woman Suffering From a Pathology Frequently Associated With the Presence of These Anti-autoantibodies Type-I Interferons","NOT_YET_RECRUITING","2024-04-12",{"date":29,"type":30},"2024-04-17","ACTUAL",{"date":32,"type":19},"2024-09",{"date":34,"type":19},"2027-03",{"name":36,"class":37},"CerbaXpert","OTHER",""]